Advisory Committee; Arthritis Advisory Committee; Termination; Removal From List of Standing Committees
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Aug. 29, 2025. Document 2025-16629. Updated Nov. 19, 2026.
- What it does
The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Arthritis Advisory Committee (Committee). Due to that termination, this final rule removes the Committee from the Agency's list of standing advisory committees in 21 CFR 14.100.
The Food and Drug Administration's summary, as published in the Federal Register.
- What changed in the regulation
1 part of Title 21 of the Code of Federal Regulations:
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Food and Drug Administration has published 103 final rules in 2026 so far, compared with 68 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
This rule is effective August 29, 2025.
The agency's dates, word for word.
The record as published
| Document number | 2025-16629 |
|---|---|
| Action | Final rule. |
| Agencies | Health and Human Services Department; Food and Drug Administration |
| Published | Aug. 29, 2025 |
| Effective date | Aug. 29, 2025 |
| Docket | FDA-2025-N-2427 |
Source: the Federal Register (public domain). The document in the Federal Register